在接受血液透析的功能衰竭患者中使用osocimab的抗凝剂:一项随机的第二阶段试验
Jeffrey I Weitz1, László B Tankó2, Jürgen Floege3
1Thrombosis and Atherosclerosis Research Institute and McMaster University, Hamilton, Ontario, Canada. weitzj@taari.ca.
Nature medicine
|February 16, 2024
概括
试验中的XIa因子抑制剂奥索西马布 (osocimab) 在血液透析中患有功能衰竭的患者中显示出较低的出血风险和良好的耐受性. 需要进一步的试验来证实这些有前途的安全性发现.
科学领域:
- 心血管医学 心血管医学
- 腎臟病學 (nephrology) 是一種醫學.
- 血液学 血液学 血液学
背景情况:
- 在血液透析中患有功能衰竭的患者面临高血栓栓塞事件的风险.
- 因子XI (FXI) 是新型抗凝血剂的潜在目标,其安全性有所改善.
- 奥索西马布是一种抑制FXIa的抗体,正在作为抗凝剂进行研究.
研究的目的:
- 评估奥索西马布在接受血液透析的功能衰竭患者的安全性和耐受性.
- 评估奥索西马布在预防血栓栓塞事件方面的疗效,以出血为关键安全终点.
主要方法:
- 一个2b期,双盲,安慰剂对照试验,涉及704名参与者,患有血液透析功能衰竭.
- 参与者被随机分配,接受较低剂量的osocimab,较高剂量的osocimab或安慰剂长达18个月.
- 共同初级结局包括临床相关的出血和中度至严重不良事件的复合.
主要成果:
- 临床相关的出血率为6.9% (较低剂量) 和4.9% (较高剂量) 的阿索西马布,与安慰剂组的7.8%相比.
- 综合不良事件发生率为51% (较低剂量),47% (较高剂量) 的osocimab,和43%的安慰剂.
- 奥索西马布在这个患者群体中显示出一般耐受性很好.
结论:
- 在血液透析中患有功能衰竭的患者中,阿索西马布似乎与低出血风险有关.
- 试验中的抗凝血剂osocimab在这个高危人群中通常耐受良好.
- 需要进行更大规模的临床试验来证实这些发现,并进一步评估osocimab的治疗潜力.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
697
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
697
01:27Dialysis
309
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
309